Braskem (NYSE:BAK – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $10.00 to $9.50 in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.
Separately, Citigroup upgraded shares of Braskem from a neutral rating to a buy rating in a report on Tuesday, August 20th.
View Our Latest Report on Braskem
Braskem Stock Performance
Braskem (NYSE:BAK – Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.30. The business had revenue of $3.66 billion for the quarter, compared to analyst estimates of $3.56 billion. Braskem had a negative return on equity of 276.59% and a negative net margin of 12.98%. On average, equities research analysts anticipate that Braskem will post -1.3 earnings per share for the current year.
Hedge Funds Weigh In On Braskem
Hedge funds have recently modified their holdings of the stock. Boston Partners acquired a new position in Braskem during the first quarter valued at approximately $627,000. Jump Financial LLC raised its stake in shares of Braskem by 4.3% during the 4th quarter. Jump Financial LLC now owns 67,392 shares of the company’s stock worth $594,000 after purchasing an additional 2,790 shares in the last quarter. Trexquant Investment LP boosted its holdings in shares of Braskem by 197.1% in the 4th quarter. Trexquant Investment LP now owns 141,852 shares of the company’s stock valued at $1,251,000 after buying an additional 94,099 shares during the last quarter. SPX Gestao de Recursos Ltda grew its stake in shares of Braskem by 266.9% in the fourth quarter. SPX Gestao de Recursos Ltda now owns 239,536 shares of the company’s stock valued at $2,113,000 after buying an additional 174,250 shares in the last quarter. Finally, Marshall Wace LLP increased its holdings in Braskem by 872.0% during the second quarter. Marshall Wace LLP now owns 268,352 shares of the company’s stock worth $1,731,000 after buying an additional 240,744 shares during the last quarter.
About Braskem
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Read More
- Five stocks we like better than Braskem
- How to Buy Cheap Stocks Step by Step
- 3 Leveraged ETFs to Multiply Returns
- Airline Stocks – Top Airline Stocks to Buy Now
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What Do S&P 500 Stocks Tell Investors About the Market?
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.